Spruce Street Capital »

Jatt Ii Acquisition Corp shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 160k 11.36

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Jatt Ii Acquisition Corp

Affinity Asset Advisors
Spruce Street Capital
Clear Street Group

View all funds holding Jatt Ii Acquisition Corp